FilingReader Intelligence
Essex Bio-Technology wins China approval for eye drops
July 23, 2025 at 12:50 PM UTC•By FilingReader AI
Essex Bio-Technology Limited announced approval of its multi-dose Diquafosol Sodium Eye Drops in China. The National Medical Products Administration granted approval for the 3% diquafosol sodium eye drops, which treat dry eye syndromes including conjunctival epithelium injury.
The approval allows Essex Bio-Technology to register and commercialise the product in the world's most populous country.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1061•Hong Kong Exchange
News Alerts
Get instant email alerts when Essex Bio-Technology publishes news
Free account required • Unsubscribe anytime